SpaceX Grew Revenue 33% Last Year -- Is That Enough to Justify the Company's $1.77 Trillion Valuation?

SpaceX is set for a June 12 IPO at a $1.77 trillion valuation, or about 94.7x last year's sales, despite revenue growth of 33% to $18.7 billion in 2025. The company posted a $4.9 billion net loss in 2025 after generating roughly $791 million in net profit in 2024, underscoring a volatile earnings profile. The article argues the valuation already prices in near-flawless execution, implying downside risk if growth or margins disappoint.

Analysis

The market is being asked to underwrite a perfect monopoly narrative at a late-cycle multiple, which creates an asymmetric setup: any slippage in launch cadence, satellite capex discipline, or ARPU expansion should compress the multiple faster than operating growth can defend it. The key second-order issue is that this is not a pure software compounding story; the business mix still contains manufacturing, launch operations, and network buildout, so incremental revenue is likely to be capital-hungry for longer than bulls expect. That makes the equity more sensitive to financing conditions and execution misses than a simple top-line screen suggests.

The competitive implication is more interesting than the headline valuation comparison. A richly priced SpaceX likely pulls attention and capital toward adjacent private-space and defense suppliers, but it also forces public comps like NVDA to trade with a premium-quality halo that may be deserved because their economics are far less capex-intensive. In other words, the article is indirectly arguing for a quality spread trade: asset-light AI beneficiaries versus asset-heavy infrastructure stories. If investors decide the SpaceX IPO is too expensive, that skepticism can spill over into other pre-IPO mega-cap technology names with similarly stretched narratives.

Near term, the main catalyst is not fundamental collapse but the first post-IPO reset in expectations: lockup-related supply, analyst initiation dispersion, and any quarter where growth remains strong but not accelerating. Over months, the more important risk is margin structure; if operating leverage fails to appear, the multiple can de-rate even with continued customer growth. The contrarian view is that the valuation may still be cheap if SpaceX becomes the default toll road for both launch and connectivity globally, but the burden of proof shifts from TAM story to free-cash-flow conversion, which is a much harder bar to clear.

Key Decisions for Investors

• Avoid chasing the SpaceX IPO in the first 2-4 weeks; let post-debut volatility and analyst coverage establish a cleaner entry point. Risk/reward is poor until the market tests whether the 90x+ sales multiple can hold under real liquidity.
• Maintain or add to NVDA on weakness as a quality-vs-capex pair trade against any SpaceX enthusiasm. The setup favors the name with materially higher margin durability and less balance-sheet strain over the next 12 months.
• If a listed SpaceX line or derivative becomes available, structure a hedged short via put spreads six to nine months out rather than outright shorting. You want exposure to multiple compression while limiting squeeze risk from IPO scarcity and narrative momentum.
• Use the IPO as a trigger to screen other capital-intensive growth names for valuation fragility; short baskets of low-FCF, high-sales-multiple tech if market breadth weakens after the debut. The trade works best if rates stay sticky and investors reprice duration risk.
• Watch for the first two earnings prints after listing; if revenue growth remains above 25% but margins do not inflect, that is the signal to add to bearish exposure. The market will likely give one grace period, but not two.